Biotechnology and genetic engineering have made it possible to create new life forms or even to re-evolve the life forms. Stem cell technology, somatic cell hybridization, genome technology, gene therapy and cloning are the buzzwords of modern scientific developments and research. The developments in these branches of science in the field of pharmaceuticals, agriculture and human healthcare are significant, with medicines such as insulin, erythro protein and interferon produced on commercial scale. In agriculture, the development of disease-resistant plant varieties, hybrid seeds and plants, nitrogen fixing microorganisms, new plant varieties with shorter life cycle, etc., and in human life science, the reconstruction of organs and creating life through cloning, biotechnology and genetic engineering are making a long-lasting impact on the human life. A section of the scientific world argues that the risk involved in commercially applying most of these scientific techniques can cause serious and irreparable damages to environment. Some others view that patenting in such areas should not be allowed for the reasons of biodiversity preservation and rights of indigenous people. Some critics of cloning technology and organ reconstruction technology foresee the danger to nature as compared to its advantages. This paper attempts to analyze the arguments against the patenting of life forms, which have been divided into the following: ethical and religious arguments; environmental implications; economic considerations; and legal issues. The author has also attempted to analyze the questions as to whether there are certain inherent values in life and whether patenting life forms violates such inherent values. The paper concludes with some important suggestions as to patenting of life forms. |